Theravance Biopharma Inc (TBPH)
Financing Cash Flow
-$2.86M
TTM · Period ending: · USD
TBPH Financing Cash Flow
Latest reported-$2.86Mperiod ending
Latest reported-$2.86Mperiod ending
TBPH TTM Cash from Financing ($123.59M → -$2.86M)
TTM financing cash flow
High-resolution chart · PNG
TBPH financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -2,858,000 | |
| -7,971,000 | |
| -3,248,000 | |
| -2,122,000 | |
| -2,094,000 | |
| -1,635,000 | |
| -2,497,000 | |
| -32,741,000 | |
| -63,773,000 | |
| -144,409,000 | |
| -198,933,000 | |
| -203,796,000 | |
| -894,418,000 | |
| -813,598,000 | |
| -758,806,000 | |
| -723,185,000 | |
| -3,445,000 | |
| 101,700,000 | |
| 91,860,000 | |
| 92,454,000 | |
| 93,777,000 | |
| -9,635,000 | |
| 263,085,000 | |
| 260,798,000 | |
| 261,627,000 | |
| 264,156,000 | |
| 1,291,000 | |
| 232,439,000 | |
| 232,251,000 | |
| 225,447,000 | |
| 225,200,000 | |
| -3,773,000 | |
| -4,240,000 | |
| 1,192,000 | |
| 1,656,000 | |
| 333,480,000 | |
| 334,750,000 | |
| 451,990,000 | |
| 479,226,000 | |
| 200,613,000 | |
| 200,050,000 | |
| 81,286,000 | |
| 81,310,000 | |
| 27,310,000 | |
| 27,654,000 | |
| 350,246,000 | |
| 370,621,000 | |
| 407,033,000 | |
| 439,943,000 | |
| 140,881,000 | |
| 123,593,000 | |
| 110,307,000 | |
| 102,417,000 |